Cidara Thera (CDTX)

$0.51 0.0014 (0.27%)

16:00 EDT CDTX Stock Quote Delayed 30 Minutes

CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Beats Revenue for Q4 2023

By InvestorPlace Earnings Apr 22, 2024

CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today?

Volume:

Previous Close -

Market Cap 25.37M

PE Ratio -1.31

EPS -0.39

Volume (Avg. Vol.) 1.86M

Day's Range $0.50 - $0.58

52-Week Range $0.50 - $1.48

Dividend & Yield N/A (N/A)

CDTX Stock Predictions, Articles, and Cidara Thera News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Mar 23, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Mar 3, 2023

We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Apr 12, 2022

Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!

6 Cheap Stocks to Buy Under $7

By Maya Sasson, Writer, TipRanks Jan 15, 2020

No matter what, investors are always after returns. These six cheap stocks can make those returns a reality in 2020.

7 Stocks the Insiders Are Buying on Sale

By Mark Putrino, CMT Oct 1, 2019

Insiders sell stocks for many reasons, but the only reason they buy is that they believe they will profit. Check out these insider buying picks.

Biggest Movers in Manufacturing Stocks Now – VCEL AUPH ONVO CC

By Portfolio Grader Dec 13, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 12, 2016

This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 5, 2016

The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – LPCN AXGN RETA CHRS

By Portfolio Grader Oct 7, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – SSNI INNL VBLT SPHS

By Portfolio Grader Jun 30, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Hottest Manufacturing Stocks Now – JAGX GBIM PRTK TROX

By Portfolio Grader Jun 17, 2016

The following stocks were moving the Manufacturing sector today.

19 Biotechnology Stocks to Sell Now

By Portfolio Grader May 23, 2016

This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Cidara receives $11M milestone payment from partner Mundipharma (NASDAQ:CDTX)

From Seeking Alpha Feb 12, 2024

Cidara (CDTX) said it has received an $11.14M milestone payment from partner Mundipharma related to the European approval of its antifungal drug Rezzayo. Read more here.

Cidara rallies 13% after hours on UK approval for Rezzayo (NASDAQ:CDTX)

From Seeking Alpha Jan 29, 2024

Shares of Cidara Therapeutics (CDTX) rallied 13% in post-market trading Monday after the company said it had received UK regulatory approval for its drug Rezzay

Cidara, Melinta announce publication of Rezzayo data in medical journal (NASDAQ:CDTX)

From Seeking Alpha Dec 5, 2023

Shares of Cidara Therapeutics (CDTX) rose 7% after it announced publication of pooled data for Rezzayo in The Lancet Infectious Diseases. Read more here.

Cidara Therapeutics shares fall as chief scientific officer sells ~18K stock (NASDAQ:CDTX)

From Seeking Alpha Sep 14, 2023

Cidara Therapeutics (CDTX) shares down 4.46% to $1.07 after the company disclosed on Sept

H.C. Wainwright Keeps Their Buy Rating on Cidara Therapeutics (CDTX)

From TipRanks Dec 2, 2022

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Cidara Therapeutics (CDTX – Research Report), with a price targ...

Analysts’ Top Healthcare Picks: uniQure (QURE), Cidara Therapeutics (CDTX)

From TipRanks Nov 25, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on uniQure (

Cidara Thera (CDTX)

CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Beats Revenue for Q4 2023

Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today?

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Cidara Thera (CDTX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CDTX Stock Predictions, Articles, and Cidara Thera News

Subscriber Sign in